SM

Sumanta Mitra

Director Director DIN 10498145
DIN 10498145 First appointment Feb 2024 Primary industry General Business
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 0 active board seats
Past companies 1 historical roles
Total affiliations 1 Since Feb 2024
Shareholding value Locked Premium profile

About Sumanta Mitra

Data last updated:

Sumanta Mitra has 2 years in corporate governance. Formerly with 1 company, such as Tricusp Pharma Private Limited. Engaged in General Business. Contributes to corporate operations.

DIN 10498145
Primary Designation Director
First Appointment 08 Feb 2024
Oldest Company Age Not Provided

Current companies

No current companies available.

Previous companies

CompanyDesignationAppointmentFoundedStatus
Tricusp Pharma Private Limited U46497WB2024PTC268201
Director08 Feb 20242024Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Tricusp Pharma Private Limited
Premium access

Shareholding and investment profile for Sumanta Mitra

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sumanta Mitra

Sumanta Mitra has 2 years in corporate governance. Formerly with 1 company, such as Tricusp Pharma Private Limited. Engaged in General Business. Contributes to corporate operations.

Sumanta Mitra is associated with 0 companies as a director.

Sumanta Mitra has expertise in General Business.

Sumanta Mitra has 2 years in corporate governance.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available